Table 34Osteoarthritis hand pain: physical modalities

Author, Year, Followup, Pain Duration, Study QualityInterventionPopulationFunction and Pain OutcomesOther Outcomes

Brosseau, 2005

4.5 months

Duration of pain:

Good

A. Low-level laser therapy (n=42): 3 applied for 1 second each to the skin overlying the radial, medial and ulnar nerves (total of 15 points irradiated); 3 sessions lasting 20 minutes per week for 6 weeks

B. Sham low-level laser therapy (n=46): same procedure as the active treatment but a sham laser probe was used.

A vs. B

Age: 64 vs. 65 years

Female: 74% vs. 83%

Medication use: 60% vs. 61%

Diagnosis of : 7.5 vs. 8.5 years

Baseline function (0-4): 2.2 vs. 2.1

Baseline pain (0-4): 2.4 vs. 2.1

Baseline pain intensity (0-100): 56.9 vs. 49.4

A vs. B

4.5 months

function: 1.9 vs. 1.7, difference 0.2 (95% −0.2 to 0.6)

pain: 1.9 vs. 1.8, difference 0.1 (95% −0.3 to 0.5)

Pain :

A vs. B

4.5 months

Patient global assessment:

Fully improved: 0% vs. 3%

Partially improved: 40% vs. 33.3%

No improvement: 60% vs. 52%

Dilek, 2013

2.25 months

Duration of pain: Mean 5.5 years

Fair

A. Dip-wrap paraffin bath therapy (n=24): patients dip both hands into 50°C paraffin bath 10 times, paraffin left on for 15 minutes, treatment administered 5 days per week for 3 weeks

B. Control group (n=22): Details ; assumed to be no treatment

Only paracetamol intake was permitted during the study

A vs. B

Age: 59 vs. 60 years

Female: 83% vs. 91%

Baseline function (0-36): 16.2 vs. 17.1

Baseline pain (0-20): 10.7 vs. 9.8

Baseline Pain at rest, median ( 0-10): 5.0 vs. 4.0

Baseline Pain during , median ( 0-10): 7.0 vs. 8.0

A vs. B

2.25 months

function: 13.8 vs. 17.8, difference −4.0 (95% −8.6 to 0.6)

pain: 6.5 vs. 9.5, difference −3 (95% −5.5 to −0.5)

Pain at rest, median: 0.0 vs. 5.0, p<0.001

Pain during , median: 5.0 vs. 7.0, p=0.05

= activity of daily living; = Australian Canadian Osteoarthritis Hand Index; =confidence interval; = not reported; = visual analog scale

a

Unless otherwise noted, followup time is calculated from the end of the treatment period

b

Data for the was presented as an average of all responses, on a 5-point Likert scale (0-4), for both the physical function (9 items) and pain (5 items) subscale

c

Data for the was presented as a sum of the values across all items within the physical function (9 items) and pain (5 items) subscales; a 5-point Likert scale (0-4) was used to rate each item resulting in score ranges of 0-36 and 0-20, respectively

From: Results

Cover of Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update
Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update [Internet].
Comparative Effectiveness Review, No. 227.
Skelly AC, Chou R, Dettori JR, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

External link. Please review our privacy policy.